Phathom Pharmaceuticals Inc logo

PHAT

Phathom Pharmaceuticals Inc

$10.15

Earnings Summary

Net Profits
$-37.81Mn

Highlights

Net Profits:

Phathom Pharmaceuticals Inc’s net profit jumped 7.01% since last year same period to $-37.81Mn in the Q1 2023. On a quarterly growth basis, Phathom Pharmaceuticals Inc has generated 31.31% jump in its net profits since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Phathom Pharmaceuticals Inc post its latest quarter earnings

EPS Estimate Current Quarter
-1.35
EPS Estimate Current Year
-1.35

Highlights

EPS Estimate Current Quarter:

Phathom Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -1.35 - a -2.27% fall from last quarter’s estimates.

EPS Estimate Current Year:

Phathom Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -1.35.

Key Ratios

Key ratios of the Phathom Pharmaceuticals Inc post its Q1 2023 earnings

Return on Assets (ROA)
-0.39
Return on Equity (ROE)
-34.89

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Phathom Pharmaceuticals Inc’s return on assets (ROA) stands at -0.39.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Phathom Pharmaceuticals Inc’s return on equity (ROE) stands at -34.89.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-10
-0.97
-1.07
-10.31%
2022-08-02
-1.03
-1.33
-29.13%
2022-11-08
-1.32
-1.32
0%